Skip to main content
. 2017 Oct 9;11(10):e0006001. doi: 10.1371/journal.pntd.0006001

Fig 6.

Fig 6

The median percentage of FoxP3 expression on CD4+ and CD8+ T-cells: (A) in patients with ENL and LL controls before, during and after treatment, (B) within ENL patients before, during and after treatment. * P≤0.05; **** P< 0.0001. Error bars show median ± interquartile range.